Curative Treatment of Candidiasis by the Live Biotherapeutic Microorganism Lactobacillus rhamnosus Lcr35(®) in the Invertebrate Model Caenorhabditis elegans: First Mechanistic Insights

The resistance of Candida albicans to conventional drug treatments, as well as the recurrence phenomena due to dysbiosis caused by antifungal treatments, have highlighted the need to implement new therapeutic methodologies. The antifungal potential of live biotherapeutic products (LBP) has already b...

Descripción completa

Detalles Bibliográficos
Autores principales: Poupet, Cyril, Veisseire, Philippe, Bonnet, Muriel, Camarès, Olivier, Gachinat, Marylise, Dausset, Caroline, Chassard, Christophe, Nivoliez, Adrien, Bornes, Stéphanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022838/
https://www.ncbi.nlm.nih.gov/pubmed/31878039
http://dx.doi.org/10.3390/microorganisms8010034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022838/
https://www.ncbi.nlm.nih.gov/pubmed/31878039
http://dx.doi.org/10.3390/microorganisms8010034

Ejemplares similares